Literature DB >> 12385522

Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone.

M Teresa Marín1, M Victoria Margarit, Gloria E Salcedo.   

Abstract

Flunarizine is a selective calcium entry blocker poorly water-soluble. In this report, the interactions of this drug with polyvinylpyrrolidone in solid dispersions, prepared according to the dissolution method using methanol as the solvent, have been investigated. For purposes of comparison physical mixtures were prepared by simple mixture and homogeneization of the two pulverized components. Combinations of flunarizine/polyvinylpyrrolidone of the following percentage proportions were prepared: 10/90, 20/80, 30/70, 40/60, 50/50, 60/40 and 80/20 (mean particle size of 0.175 mm). The physicochemical properties of solid dispersions were investigated with X-ray diffraction, infrared spectroscopy, differential scanning calorimetry and solubility in equilibrium. X-ray patterns and differential scanning calorimetry have shown that polyvinylpyrrolidone inhibits the crystallization of flunarizine when percentages drug/polymer are 10/90, 20/80 and 30/70. The infrared spectra suggest that there was no chemical interaction between flunarizine and polyvinylpyrrolidone. Equilibrium solubility studies showed that drug solubility was enhanced as the polymer content increased. In general, the solubility increase was greater in solid dispersions than in physical mixtures and the solubility in equilibrium for solid dispersions and physical mixtures at the same drug/polymer proportion showed significant differences (P < 0.05).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12385522     DOI: 10.1016/s0014-827x(02)01262-4

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  6 in total

1.  Enhancement of dissolution profile by solid dispersion (kneading) technique.

Authors:  Aftab Modi; Pralhad Tayade
Journal:  AAPS PharmSciTech       Date:  2006-08-18       Impact factor: 3.246

2.  Improved albendazole dissolution rate in pluronic 188 solid dispersions.

Authors:  Silvina G Castro; Sergio Sanchez Bruni; Carlos E Lanusse; Daniel A Allemandi; Santiago D Palma
Journal:  AAPS PharmSciTech       Date:  2010-10-14       Impact factor: 3.246

3.  Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology.

Authors:  Noorullah Naqvi Mohammed; Soumyajit Majumdar; Abhilasha Singh; Weibin Deng; Narasimha S Murthy; Elanor Pinto; Divya Tewari; Thomas Durig; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2012-09-08       Impact factor: 3.246

4.  Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer.

Authors:  Heba F Salem; Rasha M Kharshoum; Fatma I Abo El-Ela; Amr Gamal F; Khaled R A Abdellatif
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

5.  Preparation and evaluation of solid dispersions of a new antitumor compound based on early-stage preparation discovery concept.

Authors:  Peng Hou; Jian Ni; Sali Cao; Haimin Lei; Zhengjun Cai; Tao Zhang; Fang Yu; Qingzhong Tan
Journal:  AAPS PharmSciTech       Date:  2013-04-30       Impact factor: 3.246

6.  Nano-particle engineered atorvastatin delivery to support mesenchymal stem cell survival in infarcted myocardium.

Authors:  Guang-Tao Yao; Li-Ping Song; Wan-Hua Xue; Guo-Hai Su; Ai-Hua Ning; Jin Wang
Journal:  Saudi J Biol Sci       Date:  2017-04-04       Impact factor: 4.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.